Korean J Hepatol.
1998 Dec;4(4):365-380.
A Clinical Study on Small Hepatocellular Carcinoma
Abstract
- BACKGROUND/AIMS
Cases of small hepatocellular carcinoma (HCC) have been
increasing with the progress of diagnostic methods . In this study the screening
methods
for early diagnosis of HCC were re-evaluated, and comparative therapeutic
analyses were perfomed.
METHODS
A total of 110 patients with small HCC
(< 5 cm and < 4 nodules ) were retrospectively analyzed. The patients were divided
into four treatment groups ; unt reated group (No T x, n=12),
transarterial-oily-chemoembolization group (TOCE, n=43), combined treatment group
of percutaneous ethanol injection and TOCE (CEI, n=22), OP group ( OP, n=33).
RESULTS
Small HCC occupied 22.6% of total HCC cases. Only one third of small HCC
cases were detected during the regular screening. In this group, Alpha-fet oprotein
as say provided a diagnostic clue in 50% of cases, ultras onography in 71%,
and the combination of both in 88%. Five year survival rate and 5-year
non-recurrence rate in small HCC was 29% and 37% respectively. Comparative therapeutic
analys es showed t hat CEI and OP gave a better survival than TOCE in Child grade A.
CEI prolonged survival in Child grade B wher eas TOCE did not. Only TOCE was tried
and did not improve the survival in Child grade C.
CONCLUSION
1) A more strict screening is needed in high risk group of HCC.
2) As a first line of treatment in small HCC, OP or CEI can be selected in Child grade A,
and CEI in Child grade B. In Child grade C, a less invasive treatment
(PEIT , microwave coagulat ion therapy) should be investigated.